NCT04208139View on ClinicalTrials.gov

A Random Selection of Patients From the SENTRY Study Who Have a Bioconverted Sentry IVC Filter in Situ With a Minimum Dwell Time of 24 Months From a Single Center Follow up

CompletedOBSERVATIONAL
Enrollment

11

Participants

Timeline

Start Date

March 14, 2020

Primary Completion Date

September 21, 2020

Study Completion Date

October 1, 2020

Conditions
Recurrent Pulmonary Embolism (Disorder)
Interventions
DIAGNOSTIC_TEST

IVUS

IVUS

Trial Locations (1)

27607

NC Heart and Vascular Research, LLC, Raleigh

All Listed Sponsors
collaborator

Novate Medical Limited, a BTG Group Company

UNKNOWN

lead

NC Heart and Vascular Research, LLC

OTHER

NCT04208139 - A Random Selection of Patients From the SENTRY Study Who Have a Bioconverted Sentry IVC Filter in Situ With a Minimum Dwell Time of 24 Months From a Single Center Follow up | Biotech Hunter | Biotech Hunter